Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73876 - 73900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	FTL	2512	upregulated	Silver results in increased expression of FTL mRNA	19q13.33	A24216
Silver	Approved Investigational	FZD3	7976	downregulated	Silver results in decreased expression of FZD3 mRNA	8p21.1	A24216
Silver	Approved Investigational	GAS1	2619	downregulated	Silver results in decreased expression of GAS1 mRNA	9q21.33	A24216
Silver	Approved Investigational	GCLC	2729	upregulated	Silver results in increased expression of GCLC mRNA	6p12.1	A24218 A24226
Silver	Approved Investigational	GCLM	2730	upregulated	Silver results in increased expression of GCLM mRNA	1p22.1	A24218 A24226
Silver	Approved Investigational	GDA	9615	downregulated	Silver results in decreased expression of GDA mRNA	9q21.13	A24216
Silver	Approved Investigational	GLB1L3	112937	downregulated	Silver results in decreased expression of GLB1L3 mRNA	11q25	A24216
Silver	Approved Investigational	GLI2	2736	downregulated	Silver results in decreased expression of GLI2 mRNA	2q14.2	A24216
Silver	Approved Investigational	GLI2	2736	upregulated	Silver results in increased expression of GLI2 mRNA	2q14.2	A24216
Silver	Approved Investigational	GLS	2744	upregulated	Silver results in increased expression of GLS mRNA	2q32.2	A24216
Silver	Approved Investigational	GPX1	2876	downregulated	Silver results in decreased expression of GPX1 mRNA	3p21.31	A24215
Silver	Approved Investigational	GPX2	2877	upregulated	Silver results in increased expression of GPX2 mRNA	14q23.3	A24226
Silver	Approved Investigational	GPX7	2882	upregulated	Silver analog results in increased expression of GPX7 mRNA	1p32.3	A24222
Silver	Approved Investigational	GRIN2A	2903	upregulated	Silver results in increased expression of GRIN2A mRNA	16p13.2	A24216
Silver	Approved Investigational	GSTA4	2941	downregulated	Silver results in decreased expression of GSTA4 mRNA	6p12.2	A24216
Silver	Approved Investigational	HERPUD1	9709	upregulated	Silver results in increased expression of HERPUD1 mRNA	16q13	A24216
Silver	Approved Investigational	HGF	3082	downregulated	Silver results in decreased expression of HGF mRNA	7q21.11	A24216
Silver	Approved Investigational	HLA-DQA1	3117	downregulated	Silver results in decreased expression of HLA-DQA1 mRNA	6p21.32	A24216
Silver	Approved Investigational	HMOX1	3162	upregulated	Silver analog results in increased expression of HMOX1 mRNA	22q12.3	A24227 A24225
Silver	Approved Investigational	HMOX1	3162	upregulated	Silver results in increased expression of HMOX1 mRNA	22q12.3	A21765 A24218 A24217 A24226 A24216
Silver	Approved Investigational	HOXD10	3236	downregulated	Silver results in decreased expression of HOXD10 mRNA	2q31.1	A24216
Silver	Approved Investigational	HSPA1A	3303	upregulated	Silver analog results in increased expression of HSPA1A mRNA	6p21.33	A24222 A24228
Silver	Approved Investigational	HSPA1A	3303	upregulated	Silver results in increased expression of HSPA1A mRNA	6p21.33	A21765
Silver	Approved Investigational	HSPA4	3308	upregulated	Silver results in increased expression of HSPA4 mRNA	5q31.1	A24218
Silver	Approved Investigational	HSPA6	3310	upregulated	Silver results in increased expression of HSPA6 mRNA	1q23.3	A24216

Displaying entries 73876 - 73900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability